Albendazole for Hookworm Infection
Standard Treatment Regimen
For hookworm infection in healthy individuals older than two years, albendazole 400 mg orally daily for 3 consecutive days is the recommended treatment. 1
- Single-dose albendazole (400 mg once) achieves only modest cure rates of 36–69% against hookworm, with egg reduction rates of 87–97%, making it insufficient for reliable eradication. 2, 3
- The 3-day regimen (400 mg daily × 3 days) increases cure rates to 92–97% and egg reduction rates to 99.7–99.8%, providing superior efficacy. 1, 3
- Albendazole must be taken with food, preferably a fatty meal, to maximize absorption and therapeutic efficacy. 4
Pediatric Dosing (Ages 2–24 Months)
- Children older than 24 months receive the same adult dose: 400 mg daily for 3 days. 4
- For children aged 12–24 months, expert consultation is required before treatment, as safety data in this age group are limited. 4, 5
- Children under 12 months should not receive albendazole without specialist guidance. 4
Special Populations Requiring Alternative Management
Pregnant Women
- Albendazole is contraindicated in the first trimester of pregnancy due to teratogenic risk. 4
- In the second and third trimesters, use albendazole only when the therapeutic benefit clearly outweighs potential fetal risk; delay treatment until after delivery whenever clinically feasible. 4
- If treatment cannot be deferred and hookworm is causing severe anemia, consider iron supplementation as primary management with deferred antiparasitic therapy. 1
Patients with Severe Malnutrition
- Malnourished children with hookworm are at higher risk for severe anemia; prioritize nutritional rehabilitation and iron supplementation alongside antiparasitic treatment. 1
- Standard albendazole dosing (400 mg daily × 3 days) can be used, but monitor closely for adverse effects, as malnutrition may increase susceptibility to drug toxicity. 4
Chronic Liver Disease
- Albendazole is contraindicated in patients with active hepatic disease due to risk of hepatotoxicity, which occurs in up to 16% of patients on prolonged therapy. 4, 5
- If treatment is essential, use the shortest effective course (3 days) and monitor liver transaminases at baseline and every 2 weeks during therapy. 4
- Consider mebendazole as an alternative, though it also carries hepatotoxicity risk and has lower efficacy against hookworm (cure rate 29–54%). 2, 3
Benzimidazole Hypersensitivity
- Patients with known hypersensitivity to benzimidazole compounds (albendazole, mebendazole) should receive ivermectin 200 μg/kg as a single dose, repeated after 2 weeks. 1, 4
- Ivermectin is effective against hookworm and avoids cross-reactivity with benzimidazoles. 1
- Before administering ivermectin, exclude Loa loa infection in patients from Central or West Africa, as ivermectin can precipitate fatal encephalopathy in co-infected individuals. 4, 5
Monitoring and Follow-Up
- For the standard 3-day albendazole course, no routine laboratory monitoring is required. 4
- If therapy extends beyond 14 days (rare for hookworm), obtain complete blood count and liver function tests every 2 weeks, as leukopenia occurs in 10% and elevated transaminases in 16% of patients. 4, 5
- Repeat stool examination 2–3 weeks post-treatment to confirm cure; persistent infection may indicate treatment failure or reinfection. 6
Critical Clinical Pitfalls
- Do not use single-dose albendazole for hookworm treatment, as cure rates are inadequate (36–69%); always prescribe the 3-day regimen. 1, 2, 3
- Avoid administering albendazole with mineral oil (liquid paraffin), as it significantly impairs drug absorption and reduces efficacy. 4
- In patients requiring long-term corticosteroids, screen for or empirically treat Strongyloides stercoralis before starting immunosuppression, as hyperinfection syndrome is fatal. 4, 5
- For heavy hookworm infections causing severe anemia, consider adding prednisolone 40–60 mg daily and seek specialist advice, as management may require intensive care. 1